Literature DB >> 19114911

Cerebral desaturation during cardiac arrest: its relation to arrest duration and left ventricular pump function.

Keso Skhirtladze1, Beatrice Birkenberg, Bruno Mora, Andrea Moritz, Ismail Ince, Hendrik J Ankersmit, Barbara Steinlechner, Barbara Szeinlechner, Martin Dworschak.   

Abstract

OBJECTIVE: To determine the impact of brief periods of cardiac arrest (CA) on regional cerebral oxygen saturation (rSO2) in patients with low left ventricular ejection fraction (LVEF <30%).
DESIGN: Prospective observational study.
SETTING: Cardiac surgery room at a university hospital. PATIENTS: Seventy-seven consecutive patients undergoing elective implantation of a cardioverter/defibrillator in monitored anesthesia care. According to preoperative assessments, left ventricular function was classified as normal (LVEF >50%), moderately impaired (LVEF 30%-50%), or severely reduced (LVEF <30%).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: rSO2 was determined during threshold testing with concomitant induction of CA. In patients with LVEF <30%, mean baseline rSO2 (59%) was already below the lower range of normal despite normal arterial blood pressure, heart rate, and arterial oxygen saturation. rSO2 increased by 6% after 6 L/min oxygen insufflation (p < 0.05) and dropped again in each group after CA, reaching a nadir after successful defibrillation. Patients with LVEF <30% and baseline rSO2 <63% exhibited the lowest values. They also showed the highest incidence (11%) of critical cerebral desaturations (i.e., >20% drop from baseline or rSO2 value <50%). rSO2 in patients with LVEF <30% was always below that determined in patients with LVEF >30% (p < 0.05). There was a strong correlation between rSO2 values before CA and rSO2 nadir (p < 0.05). The drop in rSO2 was only moderately related to the brief CAs (p < 0.05).
CONCLUSION: These findings demonstrate that severely compromised left ventricular pump function is associated with diminished rSO2. As these patients seem to be more susceptible to critical desaturations, they may be prone to severe tissue hypoxemia unless adequate oxygen delivery is reestablished rapidly. This may contribute to the poor neurologic outcome after successful resuscitation in patients with LVEF <30%.

Entities:  

Mesh:

Year:  2009        PMID: 19114911     DOI: 10.1097/CCM.0b013e3181953d4c

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  Invasive and noninvasive assessment of cerebral oxygenation in patients with severe traumatic brain injury.

Authors:  Santiago R Leal-Noval; Aurelio Cayuela; Victoria Arellano-Orden; Antonio Marín-Caballos; Vicente Padilla; Carmen Ferrándiz-Millón; Yael Corcia; Claudio García-Alfaro; Rosario Amaya-Villar; Francisco Murillo-Cabezas
Journal:  Intensive Care Med       Date:  2010-05-26       Impact factor: 17.440

Review 2.  Cerebral oximetry in cardiac anesthesia.

Authors:  George Vretzakis; Stauroula Georgopoulou; Konstantinos Stamoulis; Georgia Stamatiou; Kosmas Tsakiridis; Paul Zarogoulidis; Nikolaos Katsikogianis; Ioanna Kougioumtzi; Nikolaos Machairiotis; Theodora Tsiouda; Andreas Mpakas; Thomas Beleveslis; Alexander Koletas; Stavros N Siminelakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

3.  Brain natriuretic peptide (BNP) may play a major role in risk stratification based on cerebral oxygen saturation by near-infrared spectroscopy in patients undergoing major cardiovascular surgery.

Authors:  Hiroshi Mukaida; Masakazu Hayashida; Satoshi Matsushita; Makiko Yamamoto; Atsushi Nakamura; Atsushi Amano
Journal:  PLoS One       Date:  2017-07-12       Impact factor: 3.240

4.  Cerebral oxygen saturation as outcome predictor after transfemoral transcatheter aortic valve implantation.

Authors:  Philipp C Seppelt; Silvia Mas-Peiro; Arnaud Van Linden; Sonja Iken; Kai Zacharowski; Thomas Walther; Stephan Fichtlscherer; Mariuca Vasa-Nicotera
Journal:  Clin Res Cardiol       Date:  2022-05-04       Impact factor: 6.138

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.